Organicell Regenerative Medicine (BPSR) News Today → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free BPSR Stock Alerts $1.04 -0.06 (-5.45%) (As of 05/14/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsHeadlinesInsider TradesSEC FilingsStock AnalysisChartFinancialsHeadlinesInsider TradesSEC Filings All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative March 4, 2024 | finanznachrichten.deZEO ScientifiX, Inc.: Organicell Regenerative Medicine Rebranding to ZEO ScientifiXDecember 17, 2023 | uk.investing.comOrganicell Regenerative Medicine Inc (OCELD)December 2, 2023 | seekingalpha.comOCELD Organicell Regenerative Medicine, Inc.November 30, 2023 | benzinga.comOrganicell Regenerative Stock (OTC:OCEL) Dividends: History, Yield and DatesNovember 27, 2023 | finance.yahoo.comOrganicell Announces 1-for-200 Reverse Stock SplitJuly 28, 2023 | finanznachrichten.deOrganicell Regenerative Medicine, Inc.: Organicell Reports Interim Results of Phase 1/2A Research ProgramJuly 26, 2023 | finance.yahoo.comOrganicell Reports Interim Results of Phase 1/2A Research ProgramJune 29, 2023 | finanznachrichten.deOrganicell Regenerative Medicine, Inc.: Organicell Welcomes Howard Golub, MD, PhD As Its New EVP/CSOJune 29, 2023 | finance.yahoo.comOrganicell Welcomes Howard Golub, MD, PhD As Its New EVP/CSOJune 23, 2023 | finanznachrichten.deOrganicell Regenerative Medicine, Inc.: Organicell Welcomes Harry Leider, MD, MBA as its New CEOJune 22, 2023 | marketwatch.com8-K: Organicell Regenerative Medicine, Inc.June 21, 2023 | finance.yahoo.comOrganicell Welcomes Harry Leider, MD, MBA as its New CEOMay 5, 2023 | marketwatch.comGlobal Regenerative Medicine Market [2023-2030] | Latest Trends and Insights | Market to Reach Worth USD 116410 MillionMay 4, 2023 | bbc.comCan regenerative wool make fashion more sustainable?April 6, 2023 | investing.comOrganicell Regenerative Medicine Inc (OCEL)April 5, 2023 | seekingalpha.comOCEL Organicell Regenerative Medicine, Inc.March 29, 2023 | marketwatch.comRegenerative Medicine Market Trends for Future Success 2023-2028March 29, 2023 | marketwatch.comRegenerative Medicine Market 2023: Growing Opportunities by 2028March 18, 2023 | finance.yahoo.comRegenerative Medicine Market Report 2023-2033February 22, 2023 | finance.yahoo.comMount Vernon, IN Regenerative Medicine Procedures Launched By NuYou TherapiesJanuary 17, 2023 | marketwatch.comRegenerative Medicine Market Regional Outlook & Size Projections with SWOT Analysis to Witness Rapid Growth 2026January 14, 2023 | finance.yahoo.comRegenerative Medicine Market to Touch USD 41.4 Billion by 2028 owing to Rising Chronic Medical AilmentsJanuary 14, 2023 | marketwatch.comRegenerative Medicine for Cartilage Market Industry Expansion Strategies till 2028 with SWOT & RISK AnalysisJanuary 14, 2023 | wsj.comOrganicell Regenerative Medicine Inc.January 11, 2023 | finance.yahoo.comThe Center for Regenerative Medicine Offers State-of-the-Art Non Surgical Solutions for Arthritic ConditionsJanuary 7, 2023 | finance.yahoo.comRegenerative Medicine Market worth $40.6 billion by 2027 - Exclusive Report by MarketsandMarkets™November 22, 2022 | finance.yahoo.comOTCMKTS : OCEL 📋 Organicell Starts Enrolling Long COVID Trial 😷November 17, 2022 | ca.finance.yahoo.comOrganicell Starts Enrolling Long COVID TrialNovember 17, 2022 | yahoo.comCan This Company’s Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?November 14, 2022 | markets.businessinsider.comEQS-News: Can This Companys Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?November 14, 2022 | benzinga.comCan This Company's Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?November 10, 2022 | benzinga.comIs It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?October 19, 2022 | sg.finance.yahoo.comOrganicell Regenerative Medicine, Inc. (OCEL)October 13, 2022 | benzinga.comOrganicell Regenerative Medicine Broadens Access to Valued Business Expertise and Relationship With New Additions to Board of DirectorsSeptember 9, 2022 | seekingalpha.comOrganicell Regenerative Medicine secures additional $11M financing for clinical trial enrollmentSeptember 9, 2022 | apnews.comOrganicell Regenerative Medicine, Inc. Secures Additional $11 Million in Financing in Preparation for Clinical Trial EnrollmentAugust 30, 2022 | finance.yahoo.comOrganicell Regenerative Medicine, Inc. Engages Law Firm McDermott Will & EmeryDecember 29, 2021 | finance.yahoo.comOrganicell Regenerative Medicine, Inc. Provides Updates of Clinical Trial ActivitiesNovember 9, 2021 | finance.yahoo.comOrganicell Regenerative Medicine, Inc. Uplist Of Common Stock To OTCQB ApprovedNovember 5, 2021 | finance.yahoo.comFINRA Approves Marketplace Name Change to Organicell Regenerative Medicine, Inc. and Trading Symbol Change To "OCEL"August 13, 2021 | finance.yahoo.comOrganicell Regenerative Medicine, Inc. (BPSR) Get Organicell Regenerative Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for BPSR and its competitors with MarketBeat's FREE daily newsletter. Email Address Top 5 Tech Stocks to Buy for 2024 (Ad)Elon Musk just Triggered a BOOM in These Stocks Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Click here to sign up for our free report & newsletter BPSR Media Mentions By Week BPSR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPSR News Sentiment▼0.000.56▲Average Medical News Sentiment BPSR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPSR Articles This Week▼00▲BPSR Articles Average Week Get Organicell Regenerative Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for BPSR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGNPF News Today AKBLF News Today DRTSW News Today ARNI News Today ARTLW News Today ASCLF News Today AWKNF News Today AXIM News Today BRRGF News Today BCTXW News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BPSR) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingTop 5 Tech Stocks to Buy for 2024Daily Market AlertsTop 5 AI Stocks to Buy for 2024Market Moving Trendsis this a buy and hold stock?Tips4TradersWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organicell Regenerative Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
